Merck
CN
高级检索
Chemical Structure Search
Search Within
文件类型

104-15-4

应用筛选条件
关键词:'104-15-4'
显示 1-30 共 836 条结果 关于 "104-15-4" 范围 技术文档
Separation of Aromatic Compounds Using Ascentis C18
selectivity, amylbenzene 11, 317-4, 538-68-1, butylbenzene B9, 020-3, 104-51- 8, o-terphenyl, T2800, 84-15-1, triphenylene, T8,260-0, 217-59-4 Conditions column: Ascentis C18, 15 cm x 4.6 mm I.D., 5 µm particles
Product Information Sheet - 104100
Catalog No. 104-LS 104-LL Maximum Assays 40 200 Contents -Catalog Numbers SIGMA 104@ Phosphatase Substrate, 104-40 2 capsules-- SIGMA 104@ Phosphatase Substrate, 104-100 -4 capsules 221
Product Information Sheet - 104105
Catalog No. 104-LS 104-LL Maximum Assays 40 200 Contents -Catalog Numbers SIGMA 104@ Phosphatase Substrate, 104-40 2 capsules-- SIGMA 104@ Phosphatase Substrate, 104-100 -4 capsules 221
Product Information Sheet - 1040
Catalog No. 104-LS 104-LL Maximum Assays 40 200 Contents -Catalog Numbers SIGMA 104@ Phosphatase Substrate, 104-40 2 capsules-- SIGMA 104@ Phosphatase Substrate, 104-100 -4 capsules 221
Product Information Sheet - 10440
Catalog No. 104-LS 104-LL Maximum Assays 40 200 Contents -Catalog Numbers SIGMA 104@ Phosphatase Substrate, 104-40 2 capsules-- SIGMA 104@ Phosphatase Substrate, 104-100 -4 capsules 221
UM-SCC-104 Squamous Carcinoma Cell Line
pharynx and larynx. Approximately 15% of HNSCC contain genomic DNA from HPV (2). In particular, HPV-16 occurs in 90-95% of all HPV-positive HNSCC cases2). UM-SCC-104 is a unique head and neck squamous
The Effective Use of Protein Kinase Inhibitors
CAM-KII 0 SkMLCK 93 104 SmMLCK 93 96 4 PKCδ 101 MKK3 95 114 94 109 MKK4 80 81 87 94 MKK6 86 79 108 113 MKK7 91 89 100 102 PI3K
The Effective Use of Protein Kinase Inhibitors
CAM-KII 0 SkMLCK 93 104 SmMLCK 93 96 4 PKCδ 101 MKK3 95 114 94 109 MKK4 80 81 87 94 MKK6 86 79 108 113 MKK7 91 89 100 102 PI3K
Product Information Sheet - NEUR1004
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1050
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1007
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1041
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1042
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1008
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1006
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1001
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1051
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
Product Information Sheet - NEUR1039
Vessel Surface/well Seeding 96 well plate 0.33 cm2 1.3 × 104 – 2.6 × 104 4 well plate 2 cm2 8 × 104 – 1.6 × 105 35 mm dish 10 cm2 4 × 105 – 8 × 105
EmbryoMax® PMEF, Strain DR4, Mytomycin C treated, passage 3
105 – 3.9 x 105 6-well plate 2.5 - 4 mL 9.5 cm2 1.2 x 105 – 1.8 x 105 12-well plate 2 mL 4 cm2 5.3 x 104 – 8.0 x 104 24-well plate 1 mL 2 cm2 2.6
EmbryoMax® PMEF, Strain DR4, Irradiated, passage 3
105 – 3.9 x 105 6-well plate 2.5 - 4 mL 9.5 cm2 1.2 x 105 – 1.8 x 105 12-well plate 2 mL 4 cm2 5.3 x 104 – 8.0 x 104 24-well plate 1 mL 2 cm2 2.6
EmbryoMax® PMEF, Strain DR4, Irradiated, passage 3
105 – 3.9 x 105 6-well plate 2.5 - 4 mL 9.5 cm2 1.2 x 105 – 1.8 x 105 12-well plate 2 mL 4 cm2 5.3 x 104 – 8.0 x 104 24-well plate 1 mL 2 cm2 2.6
Verfication summary-03-0202-00
1:32 5.75 0.9 16% 184.09 29.3 16% 102% HMN713788 3 MRD (1:4) 21.56 3.2 15% 86.25 12.6 15% - 3 1:8 11.27 0.4 4% 90.12 3.3 4% 104% 3 1:16 5.95 1.1 19% 95.17 17.9 19%
Verfication summary-03-0202-00
1:32 5.75 0.9 16% 184.09 29.3 16% 102% HMN713788 3 MRD (1:4) 21.56 3.2 15% 86.25 12.6 15% - 3 1:8 11.27 0.4 4% 90.12 3.3 4% 104% 3 1:16 5.95 1.1 19% 95.17 17.9 19%
Human STEMCCA Cre-Excisable Constitutive Polycistronic (OKSM) Lentivirus Reprogramming Kit
approximately 1 x 104 to 5 x 104 of the virus-infected cells (from Step 14h) onto the 6-well plate containing inactivated MEFs (from Step 14a). Total volume per well should be 3 mL. Day 7
Human STEMCCA Constitutive Polycistronic (OKSM) Lentivirus Reprogramming Kit
approximately 1 x 104 to 5 x 104 of the virus-infected cells (from Step 14h) onto the 6-well plate containing inactivated MEFs (from Step 14a). Total volume per well should be 3 mL. Day 7
Human STEMCCA Cre-Excisable Constitutive Polycistronic (OKS/L-Myc) Lentivirus Reprogramming Kit
Day 3-4 instead of Day 5 and thus the initial plating density needed to be scaled back to 1 x 104 cells per well. If using FibroGRO Human Foreskin Fibroblasts (Cat. No. SCC058), seed 1 x 104
EmbryoMax® PMEF, Strain DR4, Mytomycin C treated, passage 3
105 – 3.9 x 105 6-well plate 2.5 - 4 mL 9.5 cm2 1.2 x 105 – 1.8 x 105 12-well plate 2 mL 4 cm2 5.3 x 104 – 8.0 x 104 24-well plate 1 mL 2 cm2 2.6
Human iPS Cell Boost Supplement II
Day 3-4 instead of Day 5 and thus the initial plating density needed to be scaled back to 1 x 104 cells per well. If using FibroGRO Human Foreskin Fibroblasts (Cat. No. SCC058), seed 1 x 104
Serum-Free Expansion of CD34 Umbilical Cord Blood Using Stemline Hematopoietic Stem Cell Expansion Medium
101 102 103 104 CD34-APC 10 4 10 3 10 2 10 1 101 102 103 104 10 4 10 3 10 2 10 1 101 102 103 104 10 4 10 3 10 2 10 1
STEMCCA Constitutive Polycistronic (OKSM) Lentivirus Reprogramming Kit
approximately 1 x 104 to 5 x 104 of the virus-infected cells (from Step 14h) onto the 6-well plate containing inactivated MEFs (from Step 14a). Total volume per well should be 3 mL. Day 7
1/28